Article

zDHHC5 expression is increased in cardiac hypertrophy and reduced in heart failure but…

bioRxiv: the preprint server for biology · 2022 · Alice Main, author Andri Bogusalvskyii, author Jacqueline Howie, author Chien-wen Kuo, author Aileen Rankin, author Francis L. Burton, author Godfrey L. Smith, author Roger Hajjar, author George S. Baillie, author Kenneth S. Campbell, author Michael J. Shattock, author William Fuller, author

Key facts

Title zDHHC5 expression is increased in cardiac hypertrophy and reduced in heart failure but this does not correlate with changes in substrate palmitoylation
First author Alice Main, author Andri Bogusalvskyii, author Jacqueline Howie, author Chien-wen Kuo, author Aileen Rankin, author Francis L. Burton, author Godfrey L. Smith, author Roger Hajjar, author George S. Baillie, author Kenneth S. Campbell, author Michael J. Shattock, author William Fuller, author
Journal bioRxiv : the preprint server for biology
Published Aug 20, 2022
DOI 10.1101/2022.08.19.504400
Devices mentioned 050716

At a glance

  • 1–9 FDA submissions mentioned
  • None Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature